New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced the publication of a new study ...
Healio

Racial, ethnic differences seen in arteriovenous access after hemodialysis initiation

Please provide your email address to receive an email when new articles are posted on . Arteriovenous access use within 1 year after hemodialysis initiation increased in all racial/ethnic groups.
Healio

Arteriovenous access types demonstrate similar risk profiles

Please provide your email address to receive an email when new articles are posted on . The type of arteriovenous access placement, graft or fistula, used first in older patients receiving ...

Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it will host ...
FierceBiotech

Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysi

Novel Cell-Based Therapy Addresses Serious Unmet Medical Need, Aims to Reduce Need for Repeat Surgical Procedures and Improve Patient Outcomes CAMBRIDGE, Mass., Feb. 8, 2011 /PRNewswire/ -- Pervasis ...